Scholarlink

<p>Cancer is increasingly recognized as a systemic disease, extending beyond local alterations to systemic alterations in distant organs through the release of various factors that promote tumor progression and metastasis. Here, we applied hyperspectral stimulated Raman scattering (hSRS) microscopy to study metabolic alterations in the liver driven by distant tumors, revealing unprecedented accumulation of vitamin A-enriched lipid droplets. Quantitative spectral analysis uncovered increased unsaturation levels and abnormal vitamin A ester. Notably, inhibition of secretory pathways in remote tumors effectively abrogated these metabolic alterations, with FABP5 in tumor-derived extracellular vesicles identified as a key mediator. These findings uncover a unique aspect of cancer progression mechanisms, implicating tumor-driven systemic lipid metabolic remodeling and vitamin A dysregulation in metastatic progression and therapeutic response.</p><p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Tumor-secreted factors induce aberrant accumulation of vitamin A–enriched lipid droplets in the liver

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月27日

查看全文
  • Xiangjie Huang,
  • Wenyu Zhou,
  • Wenkui Hou,
  • Yihui Zhou,
  • Meixin Li,
  • Yize Zhang,
  • Qi Zhang,
  • Wei Yan,
  • Delong Zhang,
  • Hyeon Jeong Lee

摘要

Cancer is increasingly recognized as a systemic disease, extending beyond local alterations to systemic alterations in distant organs through the release of various factors that promote tumor progression and metastasis. Here, we applied hyperspectral stimulated Raman scattering (hSRS) microscopy to study metabolic alterations in the liver driven by distant tumors, revealing unprecedented accumulation of vitamin A-enriched lipid droplets. Quantitative spectral analysis uncovered increased unsaturation levels and abnormal vitamin A ester. Notably, inhibition of secretory pathways in remote tumors effectively abrogated these metabolic alterations, with FABP5 in tumor-derived extracellular vesicles identified as a key mediator. These findings uncover a unique aspect of cancer progression mechanisms, implicating tumor-driven systemic lipid metabolic remodeling and vitamin A dysregulation in metastatic progression and therapeutic response.